Skip to main content
Updating results

Neurological Disorders

  • Updated

WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.

  • Updated

WASHINGTON (AP) — Government health officials on Monday approved the first new drug for Alzheimer’s disease in nearly 20 years, disregarding warnings from independent advisers that the much-debated treatment hasn’t been shown to help slow the brain-destroying disease.

  • Updated

PHILADELPHIA (AP) — The NFL on Wednesday pledged to halt the use of “race-norming” — which assumed Black players started out with lower cognitive function — in the $1 billion settlement of brain injury claims and review past scores for any potential race bias.

Get up-to-the-minute news sent straight to your device.

Topics

all

Breaking News

Breaking Sports News

News Alert